Halozyme Therapeutics (RV7.F) Q1 2025 Earnings

18FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
0.64
0.83
1.02
1.21

Details

Expected EPS
1.10860576431
Actual EPS
1.2059081999999999
Surprise EPS
0.1
Surprise Percent
+8.78%

Description

Halozyme Therapeutics (RV7.F) has reported earnings of 1.2059081999999999 per share for Q1 2025.

0 Comments

Share your thoughts